Fenclozic acid

This classification denotes a cyclooxygenase inhibitor with the molecular formula C11H8ClNO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 58SRQ4DV53, chemically known as 4-thiazoleacetic acid, 2-(p-chlorophenyl)- but generally known as fenclozic acid, which bears US NIH Compound Identifier 28858. European Medicines Agency schedules Fenclozic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07553MIG. The term FENCLOZIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). Most nations schedule fenclozic acid under HS 29341000 and SITC 51579. As of Q4 2014, FENCLOZIC ACID remains the US FDA Preferred Term for this commodity. Fenclozic acid bears US NLM identifiers UMLS ID C0060163 and NCI Concept Code C65645. SMILES: C1=CC(=CC=C1C2=NC(=CS2)CC(=O)O)Cl.